Characterization of the binding of SCH 39166 to the five cloned dopamine receptor subtypes. 1994

M A Tice, and T Hashemi, and L A Taylor, and R A Duffy, and R D McQuade
Schering-Plough Research Institute, Kenilworth NJ 07033.

Characterization studies were conducted on the five cloned dopamine receptor subtypes (D1-D5) using the novel D1-selective antagonist, SCH 39166, as well as other related benzazepines and dopaminergic agents. The results demonstrate that SCH 39166 exhibits saturable, high-affinity binding to the D1 and D5 receptors, but binds with low affinity to the D2, D3, and D4 receptors. In contrast, the D2 antagonist haloperidol showed low affinity for the "D1-like" receptors and high affinity for the "D2-like" receptors. A series of agonists was also evaluated and the D5 receptor subtype displayed a two-site fit for the endogenous agonist dopamine, as well as for the agonist apomorphine. Differences in agonist binding among the D1-like receptors reflect the importance of the nonconserved amino acid substitutions.

UI MeSH Term Description Entries
D011869 Radioligand Assay Quantitative determination of receptor (binding) proteins in body fluids or tissue using radioactively labeled binding reagents (e.g., antibodies, intracellular receptors, plasma binders). Protein-Binding Radioassay,Radioreceptor Assay,Assay, Radioligand,Assay, Radioreceptor,Assays, Radioligand,Assays, Radioreceptor,Protein Binding Radioassay,Protein-Binding Radioassays,Radioassay, Protein-Binding,Radioassays, Protein-Binding,Radioligand Assays,Radioreceptor Assays
D011954 Receptors, Dopamine Cell-surface proteins that bind dopamine with high affinity and trigger intracellular changes influencing the behavior of cells. Dopamine Receptors,Dopamine Receptor,Receptor, Dopamine
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001552 Benzazepines Compounds with BENZENE fused to AZEPINES.
D001667 Binding, Competitive The interaction of two or more substrates or ligands with the same binding site. The displacement of one by the other is used in quantitative and selective affinity measurements. Competitive Binding
D017447 Receptors, Dopamine D1 A subfamily of G-PROTEIN-COUPLED RECEPTORS that bind the neurotransmitter DOPAMINE and modulate its effects. D1-class receptor genes lack INTRONS, and the receptors stimulate ADENYLYL CYCLASES. Dopamine D1 Receptors,Dopamine-D1 Receptor,D1 Receptors, Dopamine,Dopamine D1 Receptor,Receptor, Dopamine-D1

Related Publications

M A Tice, and T Hashemi, and L A Taylor, and R A Duffy, and R D McQuade
October 1995, Psychopharmacology,
M A Tice, and T Hashemi, and L A Taylor, and R A Duffy, and R D McQuade
February 1991, The Journal of pharmacology and experimental therapeutics,
M A Tice, and T Hashemi, and L A Taylor, and R A Duffy, and R D McQuade
September 1991, European journal of pharmacology,
M A Tice, and T Hashemi, and L A Taylor, and R A Duffy, and R D McQuade
January 1991, Psychopharmacology,
M A Tice, and T Hashemi, and L A Taylor, and R A Duffy, and R D McQuade
January 1994, Drug metabolism and disposition: the biological fate of chemicals,
M A Tice, and T Hashemi, and L A Taylor, and R A Duffy, and R D McQuade
February 2010, Bioorganic & medicinal chemistry letters,
M A Tice, and T Hashemi, and L A Taylor, and R A Duffy, and R D McQuade
March 1993, Pharmacology & toxicology,
M A Tice, and T Hashemi, and L A Taylor, and R A Duffy, and R D McQuade
January 1991, Life sciences,
M A Tice, and T Hashemi, and L A Taylor, and R A Duffy, and R D McQuade
February 2010, Bioorganic & medicinal chemistry letters,
M A Tice, and T Hashemi, and L A Taylor, and R A Duffy, and R D McQuade
July 1995, Psychopharmacology,
Copied contents to your clipboard!